[(2R,3R,4R,5R)-5-[6-(benzylamino)purin-9-yl]-3,4-dihydroxy-oxolan-2-yl ]methoxyphosphonic acid

[(2R,3R,4R,5R)-5-[6-(benzylamino)purin-9-yl]-3,4-dihydroxy-oxolan-2-yl ]methoxyphosphonic acid 구조식 이미지
카스 번호:
13484-66-7
상품명:
[(2R,3R,4R,5R)-5-[6-(benzylamino)purin-9-yl]-3,4-dihydroxy-oxolan-2-yl ]methoxyphosphonic acid
동의어(영문):
IST5-002;Nsc 255523;Benzyl-amp;Benzyl-adenosine monophosphate;N6-Benzyladenosine-5'-phosphate;5'-Adenylic acid,N-(phenylmethyl)-;N(6)-Benzyladenosine-5'-monophosphate;N6-Benzyladenosine 5'-monophosphate sodium salt;N6–BENZYLADENOSINE-5'-MONOPHOSPHATE SODIUM SALT (BAMP);[(2R,3R,4R,5R)-5-[6-(benzylamino)purin-9-yl]-3,4-dihydroxy-oxolan-2-yl ]methoxyphosphonic acid
CBNumber:
CB61254462
분자식:
C17H20N5O7P
포뮬러 무게:
437.34
MOL 파일:
13484-66-7.mol

[(2R,3R,4R,5R)-5-[6-(benzylamino)purin-9-yl]-3,4-dihydroxy-oxolan-2-yl ]methoxyphosphonic acid 속성

끓는 점
798.5±70.0 °C(Predicted)
밀도
1.81±0.1 g/cm3(Predicted)
산도 계수 (pKa)
1.86±0.10(Predicted)

안전

[(2R,3R,4R,5R)-5-[6-(benzylamino)purin-9-yl]-3,4-dihydroxy-oxolan-2-yl ]methoxyphosphonic acid C화학적 특성, 용도, 생산

[(2R,3R,4R,5R)-5-[6-(benzylamino)purin-9-yl]-3,4-dihydroxy-oxolan-2-yl ]methoxyphosphonic acid 준비 용품 및 원자재

원자재

준비 용품


[(2R,3R,4R,5R)-5-[6-(benzylamino)purin-9-yl]-3,4-dihydroxy-oxolan-2-yl ]methoxyphosphonic acid 공급 업체

글로벌( 11)공급 업체
공급자 전화 이메일 국가 제품 수 이점
NewCan Biotech Limited
+86-0571-86912261 +8613735419629
sales@newcanbio.com China 9980 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49739 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
Beijing Minruida Technology Co., Ltd. 010-82387566 18001021521;
sales@mreda.com.cn China 21450 58
Amel Pharmatech Corporation 888-4366503
sales@amelpharmatech.com China 5351 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24017 58
Guangzhou Reullei Pharmaceutical Technology Co., Ltd, 13660253774
joe@reullei.com China 1754 58
Carbosynth --
sales@carbosynth.com United Kingdom 6018 58

Copyright 2019 © ChemicalBook. All rights reserved